caffeine has been researched along with Infantile Respiratory Distress Syndrome in 21 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Apnea of prematurity, which is prevalent among infants born at less than 34 weeks gestation, is treated with caffeine, theophylline, or aminophylline." | 7.81 | Ampakines enhance weak endogenous respiratory drive and alleviate apnea in perinatal rats. ( Ding, X; Greer, JJ; Ren, J, 2015) |
| "Caffeine is commonly used to prevent or treat apnea in preterm neonates." | 5.51 | Effect of Prophylactic Caffeine on Noninvasive Respiratory Support in Preterm Neonates Weighing 1250-2000 g: A Randomized Controlled Trial. ( Armanian, AM; Feizi, A; Iranpour, R; Miladi, N, 2022) |
| "Early caffeine treatment can reduce the need for assisted ventilation in preterm infants with RDS, help with early extubation and ventilator weaning, reduce the oxygen time in the late stage, reduce the incidence of VAP, and prevent the development of apnea after extubation." | 5.22 | [Effect of early caffeine treatment on the need for respirator therapy in preterm infants with respiratory distress syndrome]. ( Duan, YH; Han, JT; Su, P; Wei, QZ; Zhang, X, 2016) |
| "Caffeine is one of the most commonly prescribed medications in preterm neonates and is widely used to treat or prevent apnea of prematurity." | 4.93 | The Role of Caffeine in Noninvasive Respiratory Support. ( Dobson, NR; Patel, RM, 2016) |
| "Apnea of prematurity, which is prevalent among infants born at less than 34 weeks gestation, is treated with caffeine, theophylline, or aminophylline." | 3.81 | Ampakines enhance weak endogenous respiratory drive and alleviate apnea in perinatal rats. ( Ding, X; Greer, JJ; Ren, J, 2015) |
| "The treatment of neonatal apnea and bradycardia with methylated xanthines--theophylline and caffeine--is generally accepted." | 3.68 | [Effect of methylxanthines on periodic respiration and acid gastroesophageal reflux in newborn infants]. ( Heimann, G; Koch, G; Skopnik, H, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Li, XL | 1 |
| Cai, YJ | 1 |
| Zhang, Z | 1 |
| Li, J | 1 |
| Chen, XW | 1 |
| Song, YY | 1 |
| Zhou, W | 1 |
| Iranpour, R | 1 |
| Armanian, AM | 1 |
| Miladi, N | 1 |
| Feizi, A | 1 |
| Sahoo, S | 1 |
| Behura, SS | 1 |
| Wasiq, MA | 1 |
| Nayak, MK | 1 |
| Mishra, A | 1 |
| Panda, SK | 1 |
| Ines, F | 1 |
| Hutson, S | 1 |
| Coughlin, K | 1 |
| Hopper, A | 1 |
| Banerji, A | 1 |
| Uy, C | 1 |
| Finer, N | 1 |
| Rich, W | 1 |
| Morales, A | 1 |
| Steen, J | 1 |
| Katheria, AC | 1 |
| Picarillo, AP | 1 |
| Carlo, W | 1 |
| Borszewska-Kornacka, MK | 1 |
| Hożejowski, R | 1 |
| Rutkowska, M | 1 |
| Lauterbach, R | 1 |
| Martin, RJ | 1 |
| Fanaroff, AA | 1 |
| Ren, J | 1 |
| Ding, X | 1 |
| Greer, JJ | 1 |
| Kribs, A | 1 |
| Hummler, H | 1 |
| Vento, G | 1 |
| Pastorino, R | 1 |
| Boni, L | 1 |
| Cota, F | 1 |
| Carnielli, V | 1 |
| Cools, F | 1 |
| Dani, C | 1 |
| Mosca, F | 1 |
| Pillow, J | 1 |
| Polglase, G | 1 |
| Tagliabue, P | 1 |
| van Kaam, AH | 1 |
| Ventura, ML | 1 |
| Tana, M | 1 |
| Tirone, C | 1 |
| Aurilia, C | 1 |
| Lio, A | 1 |
| Ricci, C | 1 |
| Gambacorta, A | 1 |
| Consigli, C | 1 |
| D'Onofrio, D | 1 |
| Gizzi, C | 1 |
| Massenzi, L | 1 |
| Cardilli, V | 1 |
| Casati, A | 1 |
| Bottino, R | 1 |
| Pontiggia, F | 1 |
| Ciarmoli, E | 1 |
| Martinelli, S | 1 |
| Ilardi, L | 1 |
| Colnaghi, M | 1 |
| Matassa, PG | 1 |
| Vendettuoli, V | 1 |
| Villani, P | 1 |
| Fusco, F | 1 |
| Gazzolo, D | 1 |
| Ricotti, A | 1 |
| Ferrero, F | 1 |
| Stasi, I | 1 |
| Magaldi, R | 1 |
| Maffei, G | 1 |
| Presta, G | 1 |
| Perniola, R | 1 |
| Messina, F | 1 |
| Montesano, G | 1 |
| Poggi, C | 1 |
| Giordano, L | 1 |
| Roma, E | 1 |
| Grassia, C | 1 |
| Ausanio, G | 1 |
| Sandri, F | 1 |
| Mescoli, G | 1 |
| Giura, F | 1 |
| Garani, G | 1 |
| Solinas, A | 1 |
| Lucente, M | 1 |
| Nigro, G | 1 |
| Del Vecchio, A | 1 |
| Petrillo, F | 1 |
| Orfeo, L | 1 |
| Grappone, L | 1 |
| Quartulli, L | 1 |
| Scorrano, A | 1 |
| Messner, H | 1 |
| Staffler, A | 1 |
| Gargano, G | 1 |
| Balestri, E | 1 |
| Nobile, S | 1 |
| Cacace, C | 1 |
| Meli, V | 1 |
| Dallaglio, S | 1 |
| Pasqua, B | 1 |
| Mattia, L | 1 |
| Gitto, E | 1 |
| Vitaliti, M | 1 |
| Re, MP | 1 |
| Vedovato, S | 1 |
| Grison, A | 1 |
| Berardi, A | 1 |
| Torcetta, F | 1 |
| Guidotti, I | 1 |
| di Fabio, S | 1 |
| Maranella, E | 1 |
| Mondello, I | 1 |
| Visentin, S | 1 |
| Tormena, F | 1 |
| Dobson, NR | 1 |
| Patel, RM | 1 |
| Wei, QZ | 1 |
| Su, P | 1 |
| Han, JT | 1 |
| Zhang, X | 1 |
| Duan, YH | 1 |
| Kassim, Z | 1 |
| Greenough, A | 2 |
| Rafferty, GF | 1 |
| Verder, H | 1 |
| Bohlin, K | 1 |
| Kamper, J | 1 |
| Lindwall, R | 1 |
| Jonsson, B | 1 |
| Sant'Anna, GM | 1 |
| Keszler, M | 1 |
| Yoder, B | 1 |
| Thomson, M | 1 |
| Coalson, J | 1 |
| Streissguth, AP | 1 |
| Barr, HM | 1 |
| Martin, DC | 1 |
| Laubscher, B | 1 |
| Dimitriou, G | 1 |
| Mehta, PN | 1 |
| Panitch, HB | 1 |
| Wolfson, MR | 1 |
| Shaffer, TH | 1 |
| Skopnik, H | 1 |
| Koch, G | 1 |
| Heimann, G | 1 |
| Boda, D | 1 |
| Németh, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Randomized Trial of Preterm Infants Receiving Caffeine and Less Invasive Surfactant Administration Compared to Caffeine and Early Continuous Positive Airway Pressure (CaLI Trial)[NCT04209946] | 180 participants (Actual) | Interventional | 2020-01-22 | Active, not recruiting | |||
| "Efficacy of a New Technique -IN-REC-SUR-E- in Preterm Neonates With Respiratory Distress Syndrome During Non Invasive Ventilation: a Randomized Controlled Trial"[NCT02482766] | 206 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for caffeine and Infantile Respiratory Distress Syndrome
| Article | Year |
|---|---|
Using Quality Improvement Tools to Reduce Chronic Lung Disease.
Topics: Adrenal Cortex Hormones; Bronchopulmonary Dysplasia; Caffeine; Chronic Disease; Continuous Positive | 2017 |
The preterm lung and airway: past, present, and future.
Topics: Adrenal Cortex Hormones; Bronchopulmonary Dysplasia; Caffeine; Combined Modality Therapy; Female; Fo | 2013 |
Ancillary therapies to enhance success of non-invasive modes of respiratory support - Approaches to delivery room use of surfactant and caffeine?
Topics: Caffeine; Delivery Rooms; Humans; Infant, Newborn; Infant, Premature; Noninvasive Ventilation; Pulmo | 2016 |
The Role of Caffeine in Noninvasive Respiratory Support.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Humans; Infant, Newb | 2016 |
Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Combined M | 2009 |
Weaning infants from mechanical ventilation.
Topics: Adrenal Cortex Hormones; Airway Extubation; Autonomic Nervous System; Caffeine; Diuretics; Humans; I | 2012 |
7 trials available for caffeine and Infantile Respiratory Distress Syndrome
| Article | Year |
|---|---|
Effect of different maintenance doses of caffeine citrate on ventilator weaning in very preterm infants with respiratory distress syndrome: a prospective randomized controlled trial.
Topics: Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Prospective Studies; Respira | 2021 |
Effect of Prophylactic Caffeine on Noninvasive Respiratory Support in Preterm Neonates Weighing 1250-2000 g: A Randomized Controlled Trial.
Topics: Apnea; Caffeine; Continuous Positive Airway Pressure; Humans; Infant; Infant, Newborn; Infant, Prema | 2022 |
Respiratory Outcome of Delivery Room Caffeine in Preterm Neonates-A Pilot, Randomized, Controlled Trial.
Topics: Caffeine; Delivery Rooms; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Pregn | 2023 |
Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.
Topics: Caffeine; Continuous Positive Airway Pressure; Humans; Infant; Infant, Newborn; Infant, Premature; M | 2021 |
Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.
Topics: Airway Extubation; Biological Products; Caffeine; Central Nervous System Stimulants; Citrates; Conti | 2016 |
[Effect of early caffeine treatment on the need for respirator therapy in preterm infants with respiratory distress syndrome].
Topics: Apnea; Caffeine; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Respiratory Dis | 2016 |
Comparative effects of theophylline and caffeine on respiratory function of prematurely born infants.
Topics: Bronchodilator Agents; Caffeine; Central Nervous System Stimulants; Humans; Infant, Newborn; Infant, | 1998 |
8 other studies available for caffeine and Infantile Respiratory Distress Syndrome
| Article | Year |
|---|---|
Shifting the boundaries for early caffeine initiation in neonatal practice: Results of a prospective, multicenter study on very preterm infants with respiratory distress syndrome.
Topics: Bronchopulmonary Dysplasia; Caffeine; Humans; Infant, Newborn; Infant, Premature; Prospective Studie | 2017 |
Ampakines enhance weak endogenous respiratory drive and alleviate apnea in perinatal rats.
Topics: Analgesics, Opioid; Animals; Animals, Newborn; Apnea; Brain Stem; Caffeine; Disease Models, Animal; | 2015 |
Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants.
Topics: Caffeine; Central Nervous System Stimulants; Functional Residual Capacity; Humans; Infant, Newborn; | 2009 |
Lung function in immature baboons with respiratory distress syndrome receiving early caffeine therapy: a pilot study.
Topics: Animals; Animals, Newborn; Biological Products; Bronchodilator Agents; Caffeine; Citrates; Continuou | 2005 |
Offspring effects and pregnancy complications related to self-reported maternal alcohol use.
Topics: Abnormalities, Drug-Induced; Alcohol Drinking; Apgar Score; Caffeine; Female; Fetus; Heart Rate; Hum | 1982 |
Dissociation between the effects of theophylline and caffeine on premature airway smooth muscles.
Topics: Acetylcholine; Animals; Animals, Newborn; Caffeine; Disease Models, Animal; Female; Humans; Infant, | 1991 |
[Effect of methylxanthines on periodic respiration and acid gastroesophageal reflux in newborn infants].
Topics: Bradycardia; Caffeine; Citrates; Drug Combinations; Drug Therapy, Combination; Gastric Acidity Deter | 1990 |
Measurement of urinary caffeine metabolites reflecting the "in vivo" xanthine oxidase activity in premature infants with RDS and in hypoxic states of children.
Topics: Biomarkers; Caffeine; Humans; Hypoxia; Infant, Newborn; Infant, Premature; Respiratory Distress Synd | 1989 |